Both Kazama et al. and Soria et al. (cited in 1) have reported
plasminogen deficiency and dysplasminogenemia with thrombotic
disorders. Similarly, abnormalities in plasminogen activator
have been associated with retinal venous occlusion. The release
of t-PA from the endothelium initiates intravascular fibrinolysis,
which is also regulated by its inhibitor, plasminogen activator
inhibitor-I.
1. Baghat N, Goldberg MF, Gascon P, Bell W, Haberman J, Zarbin
MA. Central retinal vein occlusion: review of management. Eur
J Ophthalmol 1999; 9: 165-80. |